Blueprint Medicines Corp financial data

Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 01 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316% % -22%
Quick Ratio 5% % -51%
Debt-to-equity 275% % -21%
Return On Equity -49% % 60%
Return On Assets -13% % 51%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64,582,163 shares 3.1%
Common Stock, Shares, Outstanding 64,563,911 shares 3.1%
Entity Public Float $6,747,459,120 USD 77%
Common Stock, Value, Issued $65,000 USD 3.2%
Weighted Average Number of Shares Outstanding, Basic 64,096,000 shares 4.1%
Weighted Average Number of Shares Outstanding, Diluted 66,526,000 shares 4.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $345,132,000 USD -15%
Costs and Expenses $736,428,000 USD 1.8%
Nonoperating Income (Expense) $20,413,000 USD -87%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $153,894,000 USD 47%
Income Tax Expense (Benefit) $1,835,000 USD 192%
Net Income (Loss) Attributable to Parent $155,729,000 USD 46%
Earnings Per Share, Basic -3 USD/shares 47%
Earnings Per Share, Diluted -2 USD/shares 49%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $122,245,000 USD 7.9%
Accounts Receivable, after Allowance for Credit Loss, Current $78,083,000 USD 30%
Inventory, Net $12,953,000 USD -58%
Assets, Current $702,069,000 USD -9.6%
Property, Plant and Equipment, Net $36,050,000 USD -14%
Operating Lease, Right-of-Use Asset $61,607,000 USD -14%
Other Assets, Noncurrent $60,484,000 USD 168%
Assets $1,195,604,000 USD 15%
Accounts Payable, Current $800,000 USD -84%
Employee-related Liabilities, Current $21,771,000 USD 8.8%
Accrued Liabilities, Current $122,055,000 USD 14%
Contract with Customer, Liability, Current $2,279,000 USD -69%
Liabilities, Current $250,584,000 USD 21%
Contract with Customer, Liability, Noncurrent $8,037,000 USD 73%
Operating Lease, Liability, Noncurrent $65,216,000 USD -17%
Other Liabilities, Noncurrent $6,972,000 USD 21%
Liabilities $853,473,000 USD 17%
Accumulated Other Comprehensive Income (Loss), Net of Tax $3,237,000 USD 16%
Retained Earnings (Accumulated Deficit) $2,406,535,000 USD -6.9%
Stockholders' Equity Attributable to Parent $342,131,000 USD 10%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $342,131,000 USD 10%
Liabilities and Equity $1,195,604,000 USD 15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $54,479,000 USD 46%
Net Cash Provided by (Used in) Financing Activities $9,192,000 USD -86%
Net Cash Provided by (Used in) Investing Activities $65,079,000 USD -16%
Common Stock, Shares Authorized 120,000,000 shares 0%
Common Stock, Shares, Issued 64,563,911 shares 3.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $134,092,000 USD 8.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities $21,465,000 USD 50%
Deferred Tax Assets, Valuation Allowance $798,096,000 USD 3%
Deferred Tax Assets, Gross $819,056,000 USD 2.3%
Operating Lease, Liability $82,136,000 USD -12%
Payments to Acquire Property, Plant, and Equipment $1,831,000 USD 66%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $155,119,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid $97,754,000 USD -15%
Property, Plant and Equipment, Gross $84,348,000 USD 4.8%
Operating Lease, Liability, Current $13,736,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $19,318,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year One $18,757,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $15,618,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Three $19,876,000 USD 3.2%
Deferred Tax Assets, Operating Loss Carryforwards $244,189,000 USD 5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Four $20,451,000 USD 3.2%
Operating Lease, Payments $4,663,000 USD 2.6%
Additional Paid in Capital $2,751,838,000 USD 7.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $4,459,000 USD -7.3%
Share-based Payment Arrangement, Expense $113,742,000 USD 21%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%